Prävalenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP)

S. Schipf; D. Alte; H. Völzke; N. Friedrich; R. Haring; T. Lohmann; W. Rathmann; M. Nauck; S. B. Felix; W. Hoffmann; U. John; H. Wallaschofski

doi:10.1055/s-0030-1247406

Prävalenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP)

Translated title of the contribution: Prävalenz of metabolic syndrome in Germany: Results from the study of health in pomerania (SHIP)

S. Schipf, D. Alte, H. Völzke, N. Friedrich, R. Haring, T. Lohmann, W. Rathmann, M. Nauck, S. B. Felix, W. Hoffmann, U. John, H. Wallaschofski

Research output: Contribution to journal › Article › Research › peer-review

25 Citations (Scopus)

Abstract

International studies demonstrate both an increase in the prevalence of the metabolic syndrome (MetSyn) and a shift to a manifestation in younger age. Current definitions of MetSyn require fasting blood values which are usually lacking in population-based studies. The aim of this study was to assess the prevalence of MetSyn in a north-eastern German population with non fasting blood values. Data from the representative sample of the Study of Health in Pomerania with 4310subjects (response rate 68.8%) were analysed. The MetSyn was defined according to NECP/ATPIII modified with AHA/NHLBI and IDF criteria based on non fasting blood values. The overall standardized prevalence of MetSyn was 23.8% (women 18.6%, men 29.1%), whereas the prevalence in women was lower in all age groups compared to men. In addition, we observed an age dependent increase of the MetSyn prevalence with 4.0% and 6.6% for women and men aged 2029years compared with 44.7% and 39.8% women and men aged>70years, respectively. Increasingly more subjects in younger ages are affected, but currently, age is less considered to identify persons at risk. An early detection as well as coordinated, multimodal public health interventions are required to prevent a further increase of MetSyn and the epidemic of obesity.

Translated title of the contribution	Prävalenz of metabolic syndrome in Germany: Results from the study of health in pomerania (SHIP)
Original language	German
Pages (from-to)	161-168
Number of pages	8
Journal	Diabetologie und Stoffwechsel
Volume	5
Issue number	3
DOIs	https://doi.org/10.1055/s-0030-1247406
Publication status	Published - 5 Jul 2010
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1055/s-0030-1247406

Cite this

@article{e76c33aabc2f465e8cdb1b42223ec4fe,

title = "Pr{\"a}valenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP)",

abstract = "International studies demonstrate both an increase in the prevalence of the metabolic syndrome (MetSyn) and a shift to a manifestation in younger age. Current definitions of MetSyn require fasting blood values which are usually lacking in population-based studies. The aim of this study was to assess the prevalence of MetSyn in a north-eastern German population with non fasting blood values. Data from the representative sample of the Study of Health in Pomerania with 4310subjects (response rate 68.8%) were analysed. The MetSyn was defined according to NECP/ATPIII modified with AHA/NHLBI and IDF criteria based on non fasting blood values. The overall standardized prevalence of MetSyn was 23.8% (women 18.6%, men 29.1%), whereas the prevalence in women was lower in all age groups compared to men. In addition, we observed an age dependent increase of the MetSyn prevalence with 4.0% and 6.6% for women and men aged 2029years compared with 44.7% and 39.8% women and men aged>70years, respectively. Increasingly more subjects in younger ages are affected, but currently, age is less considered to identify persons at risk. An early detection as well as coordinated, multimodal public health interventions are required to prevent a further increase of MetSyn and the epidemic of obesity.",

author = "S. Schipf and D. Alte and H. V{\"o}lzke and N. Friedrich and R. Haring and T. Lohmann and W. Rathmann and M. Nauck and Felix, {S. B.} and W. Hoffmann and U. John and H. Wallaschofski",

year = "2010",

month = jul,

day = "5",

doi = "10.1055/s-0030-1247406",

language = "German",

volume = "5",

pages = "161--168",

journal = "Diabetologie und Stoffwechsel",

issn = "1861-9002",

publisher = "Georg Thieme",

number = "3",

}

TY - JOUR

T1 - Prävalenz des Metabolischen Syndroms in Deutschland

T2 - Ergebnisse der Study of Health in Pomerania (SHIP)

AU - Schipf, S.

AU - Alte, D.

AU - Völzke, H.

AU - Friedrich, N.

AU - Haring, R.

AU - Lohmann, T.

AU - Rathmann, W.

AU - Nauck, M.

AU - Felix, S. B.

AU - Hoffmann, W.

AU - John, U.

AU - Wallaschofski, H.

PY - 2010/7/5

Y1 - 2010/7/5

N2 - International studies demonstrate both an increase in the prevalence of the metabolic syndrome (MetSyn) and a shift to a manifestation in younger age. Current definitions of MetSyn require fasting blood values which are usually lacking in population-based studies. The aim of this study was to assess the prevalence of MetSyn in a north-eastern German population with non fasting blood values. Data from the representative sample of the Study of Health in Pomerania with 4310subjects (response rate 68.8%) were analysed. The MetSyn was defined according to NECP/ATPIII modified with AHA/NHLBI and IDF criteria based on non fasting blood values. The overall standardized prevalence of MetSyn was 23.8% (women 18.6%, men 29.1%), whereas the prevalence in women was lower in all age groups compared to men. In addition, we observed an age dependent increase of the MetSyn prevalence with 4.0% and 6.6% for women and men aged 2029years compared with 44.7% and 39.8% women and men aged>70years, respectively. Increasingly more subjects in younger ages are affected, but currently, age is less considered to identify persons at risk. An early detection as well as coordinated, multimodal public health interventions are required to prevent a further increase of MetSyn and the epidemic of obesity.

AB - International studies demonstrate both an increase in the prevalence of the metabolic syndrome (MetSyn) and a shift to a manifestation in younger age. Current definitions of MetSyn require fasting blood values which are usually lacking in population-based studies. The aim of this study was to assess the prevalence of MetSyn in a north-eastern German population with non fasting blood values. Data from the representative sample of the Study of Health in Pomerania with 4310subjects (response rate 68.8%) were analysed. The MetSyn was defined according to NECP/ATPIII modified with AHA/NHLBI and IDF criteria based on non fasting blood values. The overall standardized prevalence of MetSyn was 23.8% (women 18.6%, men 29.1%), whereas the prevalence in women was lower in all age groups compared to men. In addition, we observed an age dependent increase of the MetSyn prevalence with 4.0% and 6.6% for women and men aged 2029years compared with 44.7% and 39.8% women and men aged>70years, respectively. Increasingly more subjects in younger ages are affected, but currently, age is less considered to identify persons at risk. An early detection as well as coordinated, multimodal public health interventions are required to prevent a further increase of MetSyn and the epidemic of obesity.

UR - http://www.scopus.com/inward/record.url?scp=77954100914&partnerID=8YFLogxK

U2 - 10.1055/s-0030-1247406

DO - 10.1055/s-0030-1247406

M3 - Article

AN - SCOPUS:77954100914

SN - 1861-9002

VL - 5

SP - 161

EP - 168

JO - Diabetologie und Stoffwechsel

JF - Diabetologie und Stoffwechsel

IS - 3

ER -

Prävalenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP)

Abstract

UN SDGs

Access to Document

Other files and links

Cite this